Jitka Vesela

Institute of Hematology and Transfusion Medicine

Czech Republic

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (6)

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Tereza Kabíčková

Charles University

CZECH REPUBLIC

View details

Monika Kaisrlikova

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Jiri Suttnar

Head of department

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Patrik Flodr

Lékařská Fakulta Univerzita Palackého v Olomouci

CZECH REPUBLIC

View details

Andrea Hruštincová

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

Jiri Klema

Associate professor

Czech Technical University in Prague

CZECH REPUBLIC

View details

Monika Belickova

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

J Frič

St. Anne's University Hospital

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jitka Vesela

Research Interests

Explore related searches

Contact this professor

Articles (6)

Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms

RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS

Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients

Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome

Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution

LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome

Collaborators (8)

Tereza Kabíčková

Monika Kaisrlikova

Jiri Suttnar

Patrik Flodr

Andrea Hruštincová

Jiri Klema

Monika Belickova

J Frič

Make your next move.